CD180
Basic information
Region (hg38): 5:67179613-67196799
Previous symbols: [ "LY64" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD180 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 43 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 43 | 4 | 4 |
Variants in CD180
This is a list of pathogenic ClinVar variants found in the CD180 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-67182954-A-G | not specified | Uncertain significance (Jan 16, 2024) | ||
5-67183008-G-A | not specified | Uncertain significance (Jun 12, 2023) | ||
5-67183037-C-T | Likely benign (Apr 04, 2018) | |||
5-67183041-C-G | not specified | Uncertain significance (Sep 13, 2023) | ||
5-67183060-T-C | not specified | Uncertain significance (Jan 03, 2024) | ||
5-67183091-C-T | Benign (Jun 04, 2018) | |||
5-67183180-T-G | not specified | Uncertain significance (Jan 23, 2024) | ||
5-67183240-C-T | not specified | Likely benign (Jul 05, 2023) | ||
5-67183269-A-G | not specified | Uncertain significance (Oct 28, 2023) | ||
5-67183393-C-G | not specified | Uncertain significance (Apr 07, 2023) | ||
5-67183398-T-G | not specified | Uncertain significance (Oct 20, 2023) | ||
5-67183429-G-A | not specified | Uncertain significance (Feb 17, 2023) | ||
5-67183454-A-T | not specified | Uncertain significance (Jun 23, 2023) | ||
5-67183555-T-C | Benign (Jun 12, 2018) | |||
5-67183573-G-C | not specified | Uncertain significance (Dec 09, 2023) | ||
5-67183584-G-A | not specified | Uncertain significance (Aug 14, 2023) | ||
5-67183600-C-A | not specified | Uncertain significance (Mar 29, 2022) | ||
5-67183649-C-T | Benign (May 29, 2018) | |||
5-67183744-C-G | not specified | Uncertain significance (Apr 07, 2023) | ||
5-67183753-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
5-67183800-G-A | not specified | Uncertain significance (Jan 05, 2022) | ||
5-67183869-T-G | not specified | Uncertain significance (Oct 30, 2023) | ||
5-67183920-G-A | not specified | Uncertain significance (Jun 13, 2023) | ||
5-67183927-T-G | not specified | Uncertain significance (Sep 13, 2023) | ||
5-67184014-C-T | not specified | Uncertain significance (Feb 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD180 | protein_coding | protein_coding | ENST00000256447 | 3 | 14525 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000684 | 0.916 | 125341 | 2 | 404 | 125747 | 0.00162 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.194 | 333 | 343 | 0.971 | 0.0000171 | 4416 |
Missense in Polyphen | 87 | 92.806 | 0.93744 | 1329 | ||
Synonymous | -0.303 | 143 | 138 | 1.03 | 0.00000740 | 1279 |
Loss of Function | 1.59 | 9 | 15.8 | 0.569 | 6.70e-7 | 220 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00187 | 0.00187 |
Ashkenazi Jewish | 0.00647 | 0.00647 |
East Asian | 0.000222 | 0.000217 |
Finnish | 0.00130 | 0.00129 |
European (Non-Finnish) | 0.00157 | 0.00156 |
Middle Eastern | 0.000222 | 0.000217 |
South Asian | 0.00229 | 0.00219 |
Other | 0.000981 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: May cooperate with MD-1 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) in B-cells. Leads to NF-kappa-B activation. Also involved in the life/death decision of B-cells (By similarity). {ECO:0000250}.;
- Pathway
- Regulation of toll-like receptor signaling pathway;Toll-Like Receptors Cascades;Innate Immune System;Immune System;Toll Like Receptor 4 (TLR4) Cascade
(Consensus)
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.645
- rvis_EVS
- 0.07
- rvis_percentile_EVS
- 59.11
Haploinsufficiency Scores
- pHI
- 0.0612
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.490
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.769
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd180
- Phenotype
- hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); renal/urinary system phenotype; immune system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- B cell proliferation involved in immune response;inflammatory response;positive regulation of lipopolysaccharide-mediated signaling pathway;innate immune response;cellular response to lipopolysaccharide
- Cellular component
- extracellular space;plasma membrane;integral component of membrane;extracellular matrix
- Molecular function
- protein binding